Our previous studies have demonstrated that altered TLR4 activation plays a crucial role in bladder nociception independent of inflammation and urianry dysfunction in the IC/BPS model, providing clues for potential mechanisms and therapeutic targets of IC/BPS pain.7 This evidence concerns the gene TLR4 and Bartsocas-Papas syndrome 1.